Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 0 | 0 | 3,114 | 12,292 | 4,309 |
| Gross Profit | N/A | N/A | 3,114 | 12,292 | 4,309 |
| Operating Expenses | 24,602 | 28,878 | 31,755 | 33,692 | 31,803 |
| Operating Income | -24,602 | -28,878 | -28,641 | -21,400 | -27,494 |
| Other Income | 472 | 10,228 | 35,655 | -8,008 | -3,429 |
| Pre-tax Income | -24,130 | -18,650 | 7,014 | -29,408 | -30,923 |
| Net Income Continuous | -24,130 | -18,650 | 7,014 | -29,408 | -30,923 |
| Net Income Discontinuous | N/A | 1,239 | 1,013 | 951 | 13,173 |
| Net Income | $-24,130 | $-17,411 | $8,027 | $-28,457 | $-17,750 |
| EPS Basic Total Ops | -1,747.60 | -46,336.60 | 50,118.11 | -193,768.80 | -166,954.00 |
| EPS Basic Continuous Ops | -1,747.68 | -49,634.06 | 43,902.64 | -200,250.20 | -291,131.90 |
| EPS Basic Discontinuous Ops | N/A | 3,297.41 | 6,340.66 | 6,475.72 | 123,858.80 |
| EPS Diluted Total Ops | -1,747.60 | -46,336.60 | 50,118.11 | -193,768.80 | -166,954.00 |
| EPS Diluted Continuous Ops | -1,747.68 | -49,634.06 | 43,876.82 | -200,250.20 | -291,131.90 |
| EPS Diluted Discontinuous Ops | N/A | 3,297.41 | 6,336.93 | 6,475.72 | 123,858.80 |
| EPS Diluted Before Non-Recurring Items | -1,747.60 | -48,521.99 | -188,980.41 | -200,153.20 | N/A |
| EBITDA(a) | $-24,250 | $-28,311 | $-27,740 | $-20,256 | $-26,088 |